Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced upcoming data presentations from the NeflgArd Phase 3 Study at the European Renal Association (ERA) Congress 2023.These data presentations will feature data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon (TARPEYO[®] (budesonide) delayed release capsules/Kinpeygo[®]) in patients with IgA nephropathy (IgAN). ERA will be held virtually and in Milan, Italy, June 15-18, 2023. “We are delighted that these data presentations have been selected for the upcoming ERA Congress 2023
Intervacc AB (publ) has held its Extraordinary General Meeting (”EGM”) on Friday 5 May 2023, at which a resolution on authorisation for the board of directors to resolve on rights issue of shares was made
The EGM authorised the board of directors to, in the period until the next annual general meeting, resolve on a new issue of shares with preferential rights for the company's shareholders. The total number of shares that may be issued based on the authorisation must be within the limits of the share capital according to the articles of association and may not exceed such number of
Indian start-up presented its innovation at the ISC3 Sustainable Chemistry SPOTLIGHTS event – next online event of the series on 11 MayGrowing amounts of electronic waste (e-waste) and the unsafe manner of recycling by informal workers in this sector pose substantial challenges around the world. Especially in India, given the large volume generated as well as the existing and upcoming regulation around e-waste necessitates new ways of addressing the topic to enable a safe and sustainable future, both for labourers involved as well as consumers and producers. The Start-up E[co]work provides
